- Home
- ARBEW vs KTTA Comparison
ARBEW vs KTTA Comparison
Compare ARBEW & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARBEW | KTTA |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | Israel | United States |
| Employees | 144 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 5.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARBEW | KTTA |
|---|---|---|
| Price | $0.16 | $1.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 32.4K | ★ 21.6M |
| Earning Date | 03-05-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $768,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.13 | $0.28 |
| 52 Week High | $1.25 | $3.85 |
Technical Indicators
Market Signals| Indicator | ARBEW | KTTA |
|---|---|---|
| Relative Strength Index (RSI) | 37.16 | 59.16 |
| Support Level | $0.14 | $1.09 |
| Resistance Level | $0.24 | $1.23 |
| Average True Range (ATR) | 0.03 | 0.24 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 8.74 | 46.55 |
Price Performance
Historical ComparisonAbout ARBEW Arbe Robotics Ltd. Warrant
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).